LINC02598

Across TCGA pan-cancer cohorts, LINC02598 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LINC02598 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC02598 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC02598 expression acts as an unfavorable survival marker, although some lineages such as BLCA and HNSC show a favorable association.

BLCA, KIRC, and HNSC are the cancer types where LINC02598 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Quartile	II,III,IV	0.395	0.231	<.001	96	view →
KIRC	DFS	Quartile	III,IV	0.264	0.549	.001	87	view →
HNSC	DFS	Median	IV	0.453	0.302	.009	52	view →
SKCM	DFS	Tertile	All	0.705	0.579	<.001	46	view →
LIHC	DFS	Tertile	All	0.398	0.561	.003	39	view →
CESC	OS	Quartile	All	0.875	0.683	.001	32	view →
LUSC	OS	Quartile	All	0.784	0.657	.003	29	view →
LGG	OS	Tertile	All	0.929	0.810	<.001	25	view →
STAD	DFS	Median	All	0.492	0.617	.011	21	view →
THCA	OS	Tertile	All	1.000	0.978	.005	21	view →
KIRP	OS	Median	II,III,IV	0.527	0.926	.011	15	view →
THYM	OS	Quartile	II,III,IV	0.665	1.000	.017	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

LINC02598–BLCA (DFS)

Open the BLCA breakdown →